1,427
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Serological survey of neutralizing antibodies to eight major enteroviruses among healthy population

, , , , , , , , , , , , , & show all
Pages 1-15 | Received 19 Jul 2017, Accepted 06 Nov 2017, Published online: 10 Jan 2018

References

  • JubeltBLiptonHLEnterovirus/picornavirus infectionsHandb. Clin. Neurol.2014123 379 41610.1016/B978-0-444-53488-0.00018-3
  • MaoQWangYBianLXuMLiangZEV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseasesEmerg. Microbes Infect.20165e7510.1038/emi.2016.735141264
  • Xu W. et al. Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications. Virol. J. 9, 8 (2012).
  • MirandAOutbreak of hand, foot and mouth disease/herpangina associated with Coxsackie virus A6 and A10 infections in 2010, France: a large citywide, prospective observational studyClin. Microbiol. Infect.: Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis.201218E110E11810.1111/j.1469-0691.2012.03789.x
  • LiJCharacterization of Coxsackievirus A6- and Enterovirus 71-associated hand foot and mouth disease in Beijing, China, from 2013 to 2015Front. Microbiol.201673914812011
  • MaoQCoxsackievirus A16: epidemiology, diagnosis, and vaccineHuman Vaccin. Immunother.20141036036710.4161/hv.27087
  • OsterbackRCoxsackie virus A6 and hand, foot, and mouth disease, FinlandEmerg. Infect. Dis.2009151485148810.3201/eid1509.0904382819858
  • HuYFCoxsackie virus B5, associated with neurological hand, foot and mouth disease, ChinaJ. Infect.20126518919110.1016/j.jinf.2012.03.021
  • HsuCHEpidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008J. Microbiol Immunol.201144265273
  • CooperLTJr.MyocarditisN. Engl. J. Med.20093601526153810.1056/NEJMra0800028
  • ChenPA Coxsackie virus B5-associated aseptic meningitis outbreak in Shandong Province, China in 2009J. Med. Virol.20138548348910.1002/jmv.23478
  • CarrolEDClinical and diagnostic findings of an echovirus meningitis outbreak in the north west of EnglandPostgrad. Med. J.200682606410.1136/pgmj.2005.0366082563715
  • XiaoHMolecular characterization of echovirus 30-associated outbreak of aseptic meningitis in Guangdong in 2012Virol. J.201310263.10.1186/1743-422X-10-2634016494
  • HouWConstruction and characterization of an infectious cDNA clone of Echovirus 25Virus Res.2015205414410.1016/j.virusres.2015.05.011
  • KupilaLEtiology of aseptic meningitis and encephalitis in an adult populationNeurology200666758010.1212/01.wnl.0000191407.81333.00
  • AbediGREnterovirus and Human Parechovirus Surveillance - United States, 2009-2013Mmwr. Morb. Mortal. Wkly. Rep.20156494094310.15585/mmwr.mm6434a3
  • LiuWCo-circulation and genomic recombination of Coxsackie virus A16 and Enterovirus 71 during a large outbreak of hand, foot, and mouth disease in Central ChinaPLoS ONE20149e9605110.1371/journal.pone.00960514002479
  • KapusinszkyBSzomorKNFarkasATakacsMBerencsiGDetection of non-polio enteroviruses in Hungary 2000-2008 and molecular epidemiology of Enterovirus 71, Coxsackie virus A16, and Echovirus 30Virus Genes20104016317310.1007/s11262-009-0440-4
  • BrachoMAGonzalez-CandelasFValeroACordobaJSalazarAEnterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain, 2008Emerg. Infect. Dis.2011172223223110.3201/eid1712.1103953311182
  • YanXFEpidemic characteristics of hand, foot, and mouth disease in Shanghai from 2009 to 2010: Enterovirus 71 subgenotype C4 as the primary causative agent and a high incidence of mixed infections with Coxsackie virus A16Scand. J. Infect. Dis.20124429730510.3109/00365548.2011.634433
  • YipCCEmergence of Enterovirus 71 “double-recombinant” strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71Arch. Virol.20101551413142410.1007/s00705-010-0722-0
  • Gomes MdeLde CastroCMOliveiraMJda SilvaEENeutralizing antibodies to Enterovirus 71 in Belem, BrazilMem. Inst. Oswaldo. Cruz.200297474910.1590/S0074-02762002000100006
  • AngLWSeroepidemiology of Coxsackie virus A6, Coxsackie virus A16, and Enterovirus 71 infections among children and adolescents in Singapore, 2008-2010PLoS ONE201510e012799910.1371/journal.pone.01279994444285
  • RabenauHFRichterMDoerrHWHand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in GermanyMed. Microbiol. Immunol.2010199455110.1007/s00430-009-0133-6
  • GaoFSeroepidemiology of Coxsackie virus A6, Coxsackie virus A16, and Enterovirus 71 infections in infants and children: A prospective cohort study in Jiangsu, ChinaJ. Infect.20167350951210.1016/j.jinf.2016.08.008
  • Li W. et al. Seroepidemiology of human Enterovirus 71 and Coxsackie virus A16 among children in Guangdong province, China. BMC Infect. Dis. 13, 322 (2013).
  • YangLConstruction and characterization of an infectious clone of Coxsackie virus A6 that showed high virulence in neonatal miceVirus Res.201521016516810.1016/j.virusres.2015.08.002
  • Xu L. F. et al. Atomic structures of Coxsackie virus A6 and its complex with a neutralizing antibody. Nat. Commun.8, 505 (2017).
  • YangLA neonatal mouse model for the evaluation of antibodies and vaccines against Coxsackie virus A6Antivir. Res.2016134505710.1016/j.antiviral.2016.08.025
  • Li S. et al. A neonatal mouse model of Coxsackie virus A10 infection for anti-viral evaluation. Antiviral. Res. 144, 247-255 (2017).
  • XuLProtection against lethal Enterovirus 71 challenge in mice by a recombinant vaccine candidate containing a broadly cross-neutralizing epitope within the VP2 EF loopTheranostics2014449851310.7150/thno.74573964443
  • XuLA Broadly cross-protective vaccine presenting the neighboring epitopes within the VP1 GH loop and VP2 EF loop of Enterovirus 71Sci. Rep.2015510.1038/srep129734525384
  • YangLA novel inactivated Enterovirus 71 vaccine can elicit cross-protective immunity against Coxsackie virus A16 in miceVaccine2016345938594510.1016/j.vaccine.2016.10.018
  • HouWDevelopment of a Coxsackie virus A16 neutralization test based on the enzyme-linked immunospot assayJ. Virol. Methods2015215-216566010.1016/j.jviromet.2015.02.010
  • YangLDevelopment of an enzyme-linked immunosorbent spot assay to measure serum-neutralizing antibodies against Coxsackie virus B3Clin. Vaccin. Immunol.: CVI20142131232010.1128/CVI.00359-133957675
  • HorwoodPFSeroepidemiology of human Enterovirus 71 infection among children, CambodiaEmerg. Infect. Dis.201622929510.3201/eid2201.1513234696711
  • van der SandenSMPrediction of protection against Asian Enterovirus 71 outbreak strains by cross-neutralizing capacity of serum from Dutch donors, The NetherlandsEmerg. Infect. Dis.2016221562156910.3201/eid2209.1515794994357
  • QiuJEnterovirus 71 infection: a new threat to global public health?Lancet Neurol.2008786886910.1016/S1474-4422(08)70207-2
  • National Health and Family Planning Commission of the People’s Republic of China. (http://www.nhfpc.gov.cn/).
  • He S. Z. et al. Epidemics and aetiology of hand, foot and mouth disease in Xiamen, China, from 2008 to 2015. Epidemiol. Infect. 145, 1865–1874 (2017).
  • TaoZSeroprevalence of Coxsackie virus B3 in Yantai, ChinaJpn. J. Infect. Dis.20136653753810.7883/yoken.66.537
  • MaSDuZFengMCheYLiQA severe case of co-infection with Enterovirus 71 and vaccine-derived Poliovirus type IIJ. Clin. Virol.: Off. Publ. Pan Am. Soc. Clin. Virol.201572252910.1016/j.jcv.2015.08.017